Activity value 76china Buyer&Supplier,Last transaction date:
2026-07-06
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for harbin pharmaceuticals group from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 16 transactions, with a transaction quantity of 49438.96 and a transaction weight of 54413.5.
YearTransactionsQuantityWeight
20252344673.4860846
20261649438.9654413.5
Bill of lading data
<
1/15
>
Trade date
2026/07/06
B/L No.
bzf26mnl0604
Suppliers
harbin pharmaceuticals group
Buyers
endure medical
POLs
——
PODs
manila international container terminal
Supply area
China
Purchas area
Philippines
Weight
13280kg
Amount
3874738.37
Hs code
30042099000
Product tags
box,ceftriaxone,sodium,vial,powder for injection,axon
Product description
265600 VIALS CEFTRIAXONE AS SODIUM 1G POWDER FOR INJECTION IM/IV + 10ML WFI (BOX OF 1S) HAXON
Expand
Trade date
2026/07/06
B/L No.
bzf26mnl0604
Suppliers
harbin pharmaceuticals group
Buyers
endure medical
POLs
——
PODs
manila international container terminal
Supply area
China
Purchas area
Philippines
Weight
3582kg
Amount
1893349.9
Hs code
30041016000
Product tags
box,sodium,vial,itr,powder for injection,10s,ampicillin
Product description
199000 VIALS AMPICILLIN AS SODIUM 1G POWDER FOR INJECTION IM/IV (BOX OF 10S) AMPITREX
Expand
Trade date
2026/06/01
B/L No.
bzf26mnl0514
Suppliers
harbin pharmaceuticals group
Buyers
endure medical
POLs
——
PODs
manila international container terminal
Product description
Nguyên liệu sản xuất thuốc: Ampicillin Sodium and Sulbactacm sodium (2:1) (TCNSX), Lot no: 202605001, ngày SX: 26/04/26 - Ngày HH: 03/2029; 202604008, ngày SX:03/04/26- ngày HH: 03/2029
Expand
Trade date
2026/04/25
B/L No.
108184018500
Suppliers
harbin pharmaceuticals group
Buyers
công ty cổ phần dược trang thiết bị y tế bình định bidiphar
Product description
Nguyên liệu sản xuất thuốc: Ampicillin Sodium and Sulbactacm sodium (2:1) (TCNSX), Lot no: 202601002, ngày SX: 19/12/25 - Ngày HH: 11/2028; 202604005, ngày SX:21/03/26- ngày HH: 02/2029
Expand
Trade date
2026/04/16
B/L No.
bzf26mnl0326
Suppliers
harbin pharmaceuticals group
Buyers
endure medical
POLs
——
PODs
manila international container terminal
harbin pharmaceuticals group is china Buyer&Supplier,
and primarily engages in the import and export business of products such as vial,sodium,for injection.
According to the 52wmb.com global trade database, as of 2026-07-06, the company has completed 1773 international trades,
with its main trading regions covering pakistan,ukraine,vietnam etc.
The core products include HS30042099000,HS30041016000,HS30021500000 etc,
often transported via bkk,port shanghai, port bangkok etc,
and its main trading partners are ват київмедпрепарат,bosch pharmaceutical pvt ltd.,endure medical.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on harbin pharmaceuticals group is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.